Retrospective Cohort Study of COVID-19 in Patients of the Brazilian Public Health System with SARS-CoV-2 Omicron Variant Infection

被引:3
作者
Murari, Thiago B. [1 ]
Dos Santos Fonseca, Larissa Moraes [1 ,2 ]
Pereira, Hernane B. de B. [1 ,3 ]
Nascimento Filho, Aloisio S. [1 ]
Saba, Hugo [1 ,3 ]
Scorza, Fulvio A. [4 ]
de Almeida, Antonio-Carlos G. [5 ]
Maciel, Ethel L. N. [6 ]
Mendes, Jose F. F. [7 ,8 ]
Rocha Filho, Tarcisio M. [9 ,10 ]
David, John R. [11 ,12 ]
Badaro, Roberto [1 ,2 ]
Souza Machado, Bruna Aparecida [1 ,2 ]
Moret, Marcelo A. [1 ,3 ]
机构
[1] Univ Ctr SENAI CIMATEC, Modelagem Computac, BR-41650010 Salvador, BA, Brazil
[2] Univ Ctr SENAI CIMATEC, SENAI Inst Innovat ISI Hlth Adv Syst, BR-41650010 Salvador, BA, Brazil
[3] Univ Estado Bahia, Dept Ciencias Exatas & Terra, BR-41150000 Salvador, BA, Brazil
[4] Univ Fed Sao Paulo EPM UNIFESP, Escola Paulista Med, Disciplina Neurociencia, BR-04021001 Sao Paulo, SP, Brazil
[5] Univ Fed Sao Joao del Rei UFSJ, Dept Engn Biossistemas, BR-36307352 Sao Joao Del Rei, MG, Brazil
[6] Univ Fed Espirito Santo, Lab Epidemiol, BR-29075910 Vitoria, ES, Brazil
[7] Univ Aveiro, Dept Fis, P-3880 Aveiro, Portugal
[8] Univ Aveiro, I3N, P-3880 Aveiro, Portugal
[9] Univ Brasilia, Int Ctr Condensed Matter Phys, BR-70910900 Brasilia, DF, Brazil
[10] Univ Brasilia, Inst Fis, BR-70910900 Brasilia, DF, Brazil
[11] Harvard TH Chan Sch Publ Hlth, Fac Publ Hlth, Boston, MA 02115 USA
[12] Harvard Med Sch, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
booster; vaccine effectiveness; COVID-19; VACCINATION; IMPACT;
D O I
10.3390/vaccines10091504
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several vaccines against COVID-19 are now available, based on different techniques and made by different laboratories spread around the world. With the roll out of the vaccination process in an advanced stage in many countries, the reduced risk of hospitalization due to the Omicron variant relative to the Delta variant infection, despite the higher transmission risk of Omicron, may lead to a misinterpretation of the results, as infection by Omicron is associated with a significant reduction in severe outcomes and shorter hospitalization time than the Delta variant. We compared the in-hospital mortality due to the Omicron (Jan-Mar 2022) with Gamma (Jan 2021) and Delta (Oct-Dec 2021) variants of patients in the Brazilian public health system. This study also discusses the decrease in booster vaccine effectiveness in patients hospitalized due to the Omicron variant compared with the Delta variant. Without a remodeling of vaccines for new variants, booster doses may be necessary with a shorter time interval.
引用
收藏
页数:11
相关论文
共 47 条
  • [1] Allen H., 2022, EPIDEMIOL INFECT, V151, P58, DOI DOI 10.1101/2022.02.15.22271001
  • [2] COVID-19 pandemic: what's next for public health?
    不详
    [J]. LANCET PUBLIC HEALTH, 2022, 7 (05) : E391 - E391
  • [3] [Anonymous], 2020, SOROEPI MSP SERIAL S
  • [4] [Anonymous], WHO CORONAVIRUS COVI
  • [5] [Anonymous], 2022, REPORT 50 HOSPITALIS
  • [6] Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
    Belik, Milja
    Jalkanen, Pinja
    Lundberg, Rickard
    Reinholm, Arttu
    Laine, Larissa
    Vaisanen, Elina
    Skon, Marika
    Tahtinen, Paula A.
    Ivaska, Lauri
    Pakkanen, Sari H.
    Hakkinen, Hanni K.
    Ortamo, Eeva
    Pasternack, Arja
    Ritvos, Mikael A.
    Naves, Rauno A.
    Miettinen, Simo
    Sironen, Tarja
    Vapalahti, Olli
    Ritvos, Olli
    Osterlund, Pamela
    Kantele, Anu
    Lempainen, Johanna
    Kakkola, Laura
    Kolehmainen, Pekka
    Julkunen, Ilkka
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [7] Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
    Chan, Jasper Fuk-Woo
    Kok, Kin-Hang
    Zhu, Zheng
    Chu, Hin
    To, Kelvin Kai-Wang
    Yuan, Shuofeng
    Yuen, Kwok-Yung
    [J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 221 - 236
  • [8] Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
    Cheng, Samuel M. S.
    Mok, Chris Ka Pun
    Leung, Yonna W. Y.
    Ng, Susanna S.
    Chan, Karl C. K.
    Ko, Fanny W.
    Chen, Chunke
    Yiu, Karen
    Lam, Bosco H. S.
    Lau, Eric H. Y.
    Chan, Ken K. P.
    Luk, Leo L. H.
    Li, John K. C.
    Tsang, Leo C. H.
    Poon, Leo L. M.
    Hui, David S. C.
    Peiris, Malik
    [J]. NATURE MEDICINE, 2022, 28 (03) : 486 - +
  • [9] Dejnirattisai Wanwisa, 2021, bioRxiv, DOI 10.1101/2021.12.03.471045
  • [10] Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
    Deng, Xianding
    Garcia-Knight, Miguel A.
    Khalid, Mir M.
    Servellita, Venice
    Wang, Candace
    Morris, Mary Kate
    Sotomayor-Gonzalez, Alicia
    Glasner, Dustin R.
    Reyes, Kevin R.
    Gliwa, Amelia S.
    Reddy, Nikitha P.
    San Martin, Claudia Sanchez
    Federman, Scot
    Cheng, Jing
    Balcerek, Joanna
    Taylor, Jordan
    Streithorst, Jessica A.
    Miller, Steve
    Sreekumar, Bharath
    Chen, Pei-Yi
    Schulze-Gahmen, Ursula
    Taha, Taha Y.
    Hayashi, Jennifer M.
    Simoneau, Camille R.
    Kumar, G. Renuka
    McMahon, Sarah
    Lidsky, Peter, V
    Xiao, Yinghong
    Hemarajata, Peera
    Green, Nicole M.
    Espinosa, Alex
    Kath, Chantha
    Haw, Monica
    Bell, John
    Hacker, Jill K.
    Hanson, Carl
    Wadford, Debra A.
    Anaya, Carlos
    Ferguson, Donna
    Frankino, Phillip A.
    Shivram, Haridha
    Lareau, Liana F.
    Wyman, Stacia K.
    Ott, Melanie
    Andino, Raul
    Chiu, Charles Y.
    [J]. CELL, 2021, 184 (13) : 3426 - +